Denka Pursues Domestic Approval for In Vitro Diagnostic Agent to be Used in COVID-19 Test Kits

Denka Co. Ltd. (TYO:4061) announced on July 20 that it has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), looking here to get domestic regulatory approval for an in vitro diagnostic agent to be used in simple COVID-19 test kits. To help with developing the kit, Denka has pursued collaborative research with the National Institute of Infectious…

Please subscribe to read the full story.

Log In

, , , , , ,